Belgium· BE-AMP-SAM535991-00

Onpattro 2 mg/ml

A patisiran product containing patisiran sodium, registered in Belgium by Alnylam Netherlands. The same ATC class is registered in 12 of our 19 countries.

ATC N07XX12

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedOnpattro 2 mg/mlATCN07XX12REGISTER NO.BE-AMP-SAM535991-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Patisiran is registered in 12 of 19 countries.

Countries holding a registration under ATC N07XX12 (patisiran), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Patisiran · ATC N07XX12

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Patisiran Sodium
Manufacturer
Alnylam Netherlands
Country
Belgium (BE)
ATC code
N07XX12
ATC class
Patisiran
Defined daily dose
1 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7726383
  • be_apb
    3813649

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Patisiran in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All patisiran products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ee8fdf4-7489-41d9-b3da-f3bbdf9ea049
GET /v1/drugs/3ee8fdf4-7489-41d9-b3da-f3bbdf9ea049?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Onpattro 2 mg/ml",
  "name_fr": "Onpattro 2 mg/ml",
  "name_nl": "Onpattro 2 mg/ml",
  "amp_code": "SAM535991-00",
  "strengths": [
    "2.0000",
    "3.9900"
  ],
  "pack_count": 1,
  "substances": [
    "Patisiran Sodium",
    "Patisiran",
    "Potassium Dihydrogen Phosphate",
    "Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Patisiran",
  "authorisation_numbers": [
    "EU/1/18/1320/001"
  ]
}

See everything about patisiran.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.